Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Bepranemab, a monoclonal antibody against the microtubule-binding region, showed biomarker improvement in a Phase 2 study that ended in 2024, but people enrolled in the trial had no change in cognition
Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Weight: 1419.53 g/mol CAS Number: 137525-51-0 Frequently Asked Questions What is BPC-157 used for in research
Anti-aging isnt one single lever you pull
Quality standards in the grey market were long overdue for improvement, and enforcement actions, unfortunately, are often the catalyst
To ensure the supplement's absorption and bioavailability, it is advisable to take 500 micrograms three times a day, for a total of 1500 micrograms of either methylcobalamin or 5' adenosylcobalamin
Contraindications Based on Mechanism Active mental health crisis or suicidal ideation (unproven intervention should never delay evidence-based emergency care) Pregnancy or breastfeeding (no safety data, potential for developmental effects given neuroprotective/neuroplastic actions) Bleeding disorders (BPC-157 affects thrombocyte function) Immune system disorders (concerns about potential immune reactions) Frequently Asked Questions What is BPC-157 and where does it come from
